Department of Traditional Chinese Medicine, The Third People's Hospital of Zhenjiang, Zhenjiang 212021, Jiangsu, China.
Comput Intell Neurosci. 2022 Apr 25;2022:1708133. doi: 10.1155/2022/1708133. eCollection 2022.
To explore the effect of big data analysis-based remote management combined with Yangyin Runfei decoction on coagulation function, pulmonary function, and quality of life (QOL) of pulmonary tuberculosis (PTB) patients.
A total of 90 PTB patients treated in our hospital from May 2019 to May 2020 were selected as the subjects and divided into the experimental group (EG) and control group (CG) according to their admission order, with 45 cases each. Patients in CG accepted routine management and treatments and those in EG received big data analysis-based remote management combined with Yangyin Runfei decoction, so as to compare the clinical indicators between the two groups.
Compared with CG after treatment, EG presented an obviously higher total clinical effective rate, various pulmonary function indicators, and GQOLI-74 score ( < 0.001) and significantly lower various coagulation indicators and inflammatory factor indicators ( < 0.001).
Performing big data analysis-based remote management combined with Yangyin Runfei decoction to PTB patients can effectively improve their QOL and pulmonary function and present a higher application value compared to routine management and treatments. Further research will be conducive to establishing a better solution for patients. This trial is registered with Clinical Study Registration Number: https://clinicaltrials.gov/ct2/show/ChiCTR2200057257.
探讨基于大数据分析的远程管理联合养阴润肺汤对肺结核（PTB）患者凝血功能、肺功能和生活质量（QOL）的影响。
选取 2019 年 5 月至 2020 年 5 月我院收治的 90 例肺结核患者为研究对象，根据入院顺序分为实验组（EG）和对照组（CG），每组 45 例。CG 组接受常规管理和治疗，EG 组接受基于大数据分析的远程管理联合养阴润肺汤治疗，比较两组患者的临床指标。
与 CG 组治疗后比较，EG 组总临床有效率、各项肺功能指标及 GQOLI-74 评分明显更高，各项凝血指标及炎症因子指标明显更低（均<0.001）。
对肺结核患者实施基于大数据分析的远程管理联合养阴润肺汤治疗，能有效改善患者的 QOL 和肺功能，与常规管理和治疗相比具有更高的应用价值。进一步研究有助于为患者建立更好的解决方案。本研究已在 ClinicalTrials.gov 注册，注册号为 ChiCTR2200057257。
